200 related articles for article (PubMed ID: 26073177)
1. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
Marianelli C; Graziani C; Santangelo C; Xibilia MT; Imbriani A; Amato R; Neri D; Cuccia M; Rinnone S; Di Marco V; Ciuchini F
J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.
Turkmani A; Ioannidis A; Christidou A; Psaroulaki A; Loukaides F; Tselentis Y
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():24. PubMed ID: 17014707
[TBL] [Abstract][Full Text] [Related]
5. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
8. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
10. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
11. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
[TBL] [Abstract][Full Text] [Related]
12. Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis.
Coban AY; Tanyel E; Tasdelen Fisgin N; Darka O; Tulek N; Durupinar B
J Chemother; 2007 Oct; 19(5):596-8. PubMed ID: 18073161
[No Abstract] [Full Text] [Related]
13. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of several antimicrobial combinations against Brucella canis and Brucella melitensis strains isolated from dogs.
Mateu-de-Antonio EM; Martín M
Vet Microbiol; 1995 Jun; 45(1):1-10. PubMed ID: 7653024
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiological and microbiological study of brucellosis in Kuwait.
Dimitrov Ts; Panigrahi D; Emara M; Awni F; Passadilla R
Med Princ Pract; 2004; 13(4):215-9. PubMed ID: 15181327
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline: its potential for treatment of brucellosis.
Dizbay M; Kilic S; Hizel K; Arman D
Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of lomefloxacin against Brucella melitensis.
Qadri SM; al-Sedairy S; Ueno Y
Diagn Microbiol Infect Dis; 1990; 13(3):277-9. PubMed ID: 2383977
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of azithromycin against Brucella melitensis.
Qadri SM; Halim MA; Ueno Y; Abumustafa FM; Postle AG
Chemotherapy; 1995; 41(4):253-6. PubMed ID: 7555205
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Thyroid Gland Abscess Caused by Brucella melitensis].
Kazaz I; Yazici E; Aygar İS; Hoşbul T
Mikrobiyol Bul; 2024 Apr; 58(2):217-223. PubMed ID: 38676588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
